James Willhite was an editor with The Wall Street Journal's money & investing team based in London.

Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...

AngioDynamics, currently sporting a Zacks Rank #1 (Strong Buy), reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of 3 cents against the Zacks Consensus Estimate of a loss of 13 ...

AngioDynamics, currently sporting a Zacks Rank #1 (Strong Buy), reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of 3 cents against the Zacks Consensus Estimate of a loss of 13 ...

Penumbra, Inc. PEN reported first-quarter 2025 adjusted earnings per share (EPS) of 83 cents, which surpassed the Zacks ...

Thermo Fisher Scientific Inc.'s TMO first-quarter 2025 adjusted earnings per share (EPS) of $5.15 beat the Zacks Consensus ...

COO The Cooper Companies, Inc.

Concentra Group Holding Parent, Inc. CON recently announced a definitive agreement to acquire Pivot Onsite Innovations from Athletico Physical Therapy. Pivot operates over 200 onsite health ...

Allegiant Travel Company (NASDAQ: ALGT) today reported preliminary passenger traffic results for March 2025. Scheduled ...